Business Segments (Tables)

9 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Schedule of Segment Financial Information

The following tables set forth financial information by segment:

Three months ended September 30, 2024	Consumer Products segment		Ingredients segment		Analytical Reference Standards and Services segment		Corporate and other		Total
(In thousands)
Net sales	$	18,123	$	6,673	$	784	$	—	$	25,580
Cost of sales	6,512		2,176		652		—		9,340
Gross profit	11,611		4,497		132		—		16,240
Operating expenses:
Sales and marketing	6,918		6		120		—		7,044
Research and development	901		389		—		—		1,290
General and administrative	—		—		—		6,304		6,304
Operating expenses	7,819		395		120		6,304		14,638
Operating income (loss)	$	3,792	$	4,102	$	12	$	(6,304)	$	1,602

Three months ended September 30, 2023	Consumer Products segment		Ingredients segment		Analytical Reference Standards and Services segment		Corporate and other		Total
(In thousands)
Net sales	$	17,400	$	1,424	$	671	$	—	$	19,495
Cost of sales	6,024		739		763		—		7,526
Gross profit (loss)	11,376		685		(92)		—		11,969
Operating expenses:
Sales and marketing	5,934		—		101		—		6,035
Research and development	1,142		99		—		—		1,241
General and administrative	—		—		—		5,840		5,840
Operating expenses	7,076		99		101		5,840		13,116
Operating income (loss)	$	4,300	$	586	$	(193)	$	(5,840)	$	(1,147)

Nine Months Ended September 30, 2024	Consumer Products segment		Ingredients segment		Analytical Reference Standards and Services segment		Corporate and other		Total
(In thousands)
Net sales	$	54,121	$	14,062	$	2,289	$	—	$	70,472
Cost of sales	19,451		5,558		2,074		—		27,083
Gross profit	34,670		8,504		215		—		43,389
Operating expenses:
Sales and marketing	20,291		84		378		—		20,753
Research and development	3,731		970		—		—		4,701
General and administrative	—		—		—		17,320		17,320
Operating expenses	24,022		1,054		378		17,320		42,774
Operating income (loss)	$	10,648	$	7,450	$	(163)	$	(17,320)	$	615

Nine Months Ended September 30, 2023	Consumer Products segment		Ingredients segment		Analytical Reference Standards and Services segment		Corporate and other		Total
(In thousands)
Net sales	$	51,924	$	8,252	$	2,198	$	—	$	62,374
Cost of sales	18,387		3,852		2,292		—		24,531
Gross profit (loss)	33,537		4,400		(94)		—		37,843
Operating expenses:
Sales and marketing	19,599		37		282		—		19,918
Research and development	3,278		521		—		—		3,799
General and administrative	—		—		—		19,557		19,557
Operating expenses	22,877		558		282		19,557		43,274
Operating income (loss)	$	10,660	$	3,842	$	(376)	$	(19,557)	$	(5,431)

Schedule of Disaggregation of Revenue

Disaggregated revenues are as follows:

Three Months Ended September 30, 2024	Consumer Products Segment		Ingredients Segment		Analytical Reference Standards and Services Segment		Total
(In thousands)
Tru Niagen®, Consumer Product	$	18,123	$	—	$	—	$	18,123
Food-grade Niagen®	—		5,760		—		5,760
Pharmaceutical-grade Niagen®	—		900		—		900
Subtotal Niagen® Related	18,123		6,660		—		24,783
Other Ingredients	—		13		—		13
Reference Standards	—		—		759		759
Consulting and Other	—		—		25		25
Subtotal Other Goods and Services	—		13		784		797
Total Net Sales	$	18,123	$	6,673	$	784	$	25,580

Three Months Ended September 30, 2023	Consumer Products Segment		Ingredients Segment		Analytical Reference Standards and Services Segment		Total
(In thousands)
Tru Niagen®, Consumer Product	$	17,400	$	—	$	—	$	17,400
Food-grade Niagen®	—		1,424		—		1,424
Pharmaceutical-grade Niagen®	—		—		—		—
Subtotal Niagen® Related	17,400		1,424		—		18,824
Other Ingredients	—		—		—		—
Reference Standards	—		—		654		654
Consulting and Other	—		—		17		17
Subtotal Other Goods and Services	—		—		671		671
Total Net Sales	$	17,400	$	1,424	$	671	$	19,495

Nine Months Ended September 30, 2024	Consumer Products Segment		Ingredients Segment		Analytical Reference Standards and Services Segment		Total
(In thousands)
Tru Niagen®, Consumer Product	$	54,121	$	—	$	—	$	54,121
Food-grade Niagen®	—		12,992		—		12,992
Pharmaceutical-grade Niagen®	—		900				900
Subtotal Niagen® Related	54,121		13,892		—		68,013
Other Ingredients	—		170		—		170
Reference Standards	—		—		2,195		2,195
Consulting and Other	—		—		94		94
Subtotal Other Goods and Services	—		170		2,289		2,459
Total Net Sales	$	54,121	$	14,062	$	2,289	$	70,472

Nine Months Ended September 30, 2023	Consumer Products Segment		Ingredients Segment		Analytical Reference Standards and Services Segment		Total
(In thousands)
Tru Niagen®, Consumer Product	$	51,924	$	—	$	—	$	51,924
Food-grade Niagen®	—		7,822		—		7,822
Pharmaceutical-grade Niagen®	—		—		—		—
Subtotal Niagen® Related	51,924		7,822		—		59,746
Other Ingredients	—		430		—		430
Reference Standards	—		—		2,122		2,122
Consulting and Other	—		—		76		76
Subtotal Other Goods and Services	—		430		2,198		2,628
Total Net Sales	$	51,924	$	8,252	$	2,198	$	62,374

Schedule of Major Customers

Percentage of net sales from major customers of the Company’s consumer products segment and ingredients segment for the periods indicated were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
Major Customers	2024		2023		2024		2023
A.S. Watson Group - Related Party (1)	*		16.0	%	12.4	%	15.7	%
Life Extension	16.8	%	*		13.3	%	*

* Represents less than 10%

(1) For additional information regarding the relationship between the Company and A.S. Watson Group, see Note 6, Related Party Transactions.

The percentage of the amounts due from major customers to total trade receivables, net for the periods indicated were as follows:

	Percentage of the Company's Total Trade Receivables
Major Customers	At September 30, 2024		At December 31, 2023
A.S. Watson Group - Related Party (1)	28.6	%	52.7	%
Amazon Marketplaces	*		12.2	%
Life Extension	33.3	%	16.1	%
Wells Pharma of Houston	12.7	%	*

* Represents less than 10%

(1) For additional information regarding the relationship between the Company and A.S. Watson Group, see Note 6, Related Party Transactions.